D. Polese, A. Amato De Serpis, A. De Bartolomeis, G. Muscettola - Vol. 6, Marzo 2000, num.1
Testo Bibliografia Summary Riassunto Indice
Anedonia: dai modelli sperimentali
alla psicopatologia
Anhedonia: from experimental models to psychopathology
1 Ribot J.
La psychologie des sentiments.
Paris: Felix Alcan 1 N.R 1896.
2 Kraepelin E.
Dementia praecox and paraphrenia.
Edimburgh: E & Livingstone (Barclay RM, trans.) 1919 (original work published
1913).
3 Bleuler E.
Dementia praecox, or the group of schizophrenias.
NY: International University Press (Zinkin J & Lewis NDC, trans.)
1950 (Original work published 1911).
4 Loas G, Salinas E, Guelfi JD, Samuel-Lajeunesse B.
Physical anhedonia in major depressive disorder.
Journal of Affective Disorders 1992;25:139-146.
5 Zimmermann M, Black DW, Coryell W.
Diagnostic criteria for melancholia: the comparative validity of DSM-III
and DSM-III-R.
Archives of General Psychiatric 1989;46:361-368.
6 Ettenberg A.
Anhedonia.
In: Costello CG, ed. Symptoms of schizophrenia. NY: Wiley 1993:121-144.
7 Oei TI, Verhoeven WM, Westenberg HG, Zwart FM, van Ree JM.
Anhedonia, suicide ideation and dexamethasone nonsuppression in depressed
patients.
Journal of Psychiatry Research 1990;24:25-35.
8 Robbins DR, Alessi NE.
Depressive simptoms and suicidal Behavior in adolescents.
American Journal of Psychiatry 1985;151:489-498.
9 Silverstone PH.
Is anhedonia a good measure of depression?
Acta Psychiatrica Scandinavica 1991;83:249-250.
10 Koob GF, Le Moal M.
Drug Abuse:Hedonic Homeostatic Dysregulation.
Science 1997;278:52-58.
11 Bermazhon PC, Siris SG.
Akinesia: a syndrome common to parkinsonism, retarded depression and negative
simptoms of schizophrenia.
Comprehensive Psychiatry 1992;33:221-232.
12 Chapman LJ, Chapman JP, Kwapil TR, Eckbalad M, Zinser MC.
Putatively psychosis-prone subjects ten years later.
Journal of Abnormal Psychology 1994;130:171-183.
13 Meehl PE.
Schizotaxia, schizotypy and schizophrenia.
American Psychologist 1962;17:827-838.
14 Meehl PE.
Toward an integrated theory of schizotaxia, schizotypy and schizophrenia.
Journal of Personality Disorders 1990;4:1-99.
15 Rado S.
Psychoanalysis of behavior: The collected papers of Sando Rado. Vol 2.
New York: Grune & Stratton 1962.
16 Blanchard JJ, Muesr KT, Bellack AS.
Positive and negative Affect, and Social functioning in Schizophrenia.
Schizophrenia Bullettin 1998;24:413-424.
17 Ljungberg T, Apicella P, Shultz W.
Response of monkey dopamine neurons during delayed alternation performance.
Journal of Neurophysiology 1992;67:145-163.
18 Argyropoulos SV, Nutt DJ.
Anhedonia and chronic mild stress model in depression.
Psychopharmacology 1997;134:333-336.
19 Fritze J, Beckman H.
The cholinergic agonist RS86: a pharmacopsychological study.
Neuropsychobiology 1988;19:35-39.
20 Sano M.
Basal ganglia deseases and depression.
Neuropsychology and Behavior Medicine 1991;4:41-48.
21 Ebmeier K, Ebert D.
Imaging functional change and dopaminergic activity in depression.
In: Beniner RJ, Palomo T, Archer T, eds. Dopamine disease state. Madrid:
Fundación Cerebro y Mente 1996:511-522.
22 Frecska E, Arató M, Banki CM, Mohar K, Perenyi A, Bagdy G, Fekete MI.
Prolactin response to fentanyl in depression.
Biological Psychiatry 1989;25:692-696.
23 Papp M, Lappas S, Muscat R, Willner P.
Attenuation of place preference conditioning, but not place avversion conditioning
by chronic mild stress.
Journal of Psychopharmacology 1992;6:352-356.
24 Berridge KC, Robinson TE.
What is the role of dopamine in reward: hedonic impact, reward learning
or incentive salience?
Brain Research Reviews 1998;309-369.
25 Crow TJ.
Catecholamine-containing neurones and electrical self-stimulation: a review
of some data.
Psycological Medicine 1972;2:414-421.
26 Fouriezos G, Wise RA.
Pimozide-induced extinction of intracranial self-stimulation: Response
patterns rule out moto performance deficits.
Brain Research 1980;103:377-380.
27 German DC, Bowden DM.
Catecholamine systems as the neural substrate of intracranial self-stimulation:
a hypothesis.
Brain Research 1974;73:381-419.
28 Lippa AS, Antleman S, Fisher A, Canfield D.
Neurochemical mediation of "reward": a significant role for dopamine.
Pharmacology, Biochemistry and Behavior 1973;1:25-28.
29 Fouriezos G, Hansson P, Wise RA.
Neuroleptic-induced attivation of brain stimulation "reward"
in rats.
Journal of Comprehensive and Physiological Psycology 1978;92:661-671.
30 Wise RA.
Neuroleptics and operant Behavior: the anhedonia hypotesis.
Behavioral Brain Science 1982;5:39-87.
31 Wise RA.
The anhedonia hypotesis: Mark III.
Behavioral Brain Science 1985;8:178-186.
32 Wise RA, Spindler J, de Witt H, Gerberg GJ.
Neuroleptic induced ‘anhedonia’ in rats: pimozide blocks "reward"
quality of food.
Science 1978;201:262-264.
33 Bailey CS, Hsiao S, King JE.
Hedonic reactivity to sucrose in rats: modification by pimozide.
Physiology and Behavior 1986;38:447-452.
34 Blackburn JR, Pfaus JF, Phillips AG.
Dopamine functions in appetitive and defensive Behaviors.
Progress in Neurobiology 1992;39:247-279.
35 Ettemberg A.
Dopamine, neuroleptics and Behavior.
Neuroscience and Biobehavioral Reviews 1989;13:105-111.
36 Ettemberg A, Camp CH.
Haloperidol induces a partial reinforcement extinction effect in rats:
implications for a dopamine involvment in food reward.
Pharmacology, Biochemistry and Behavior 1986;15:813-821.
37 Geary N, Smith GP.
Pimozide decreases the positive reinforcing effect of sham fed sucrose
in the rat.
Pharmacology, Biochemistry and Behavior 1985;22:787-790.
38 Horvitz JC, Ettemberg A.
Haloperidol block the response-reinstating effects of food reward: a methodology
for separating neuroleptic effects on reinforcement and motor processes.
Pharmacology, Biochemistry and Behavior 1988;31:861-865.
39 Hsiao S, Smith GP.
Raclopride reduces sucrose preference in rats.
Pharmacology, Biochemistry and Behavior 1995;50:121-125.
40 Panksepp J.
Affective Neuroscience: The Foundation of Human and Animal Emotions.
Oxford U.K.: Oxford University Press 1988.
41 Schneider LH, Davis JD, Watson CA, Smith GP.
Similar effects of raclopride and reduced sucrose concentration on the
microstructure of sucrose sham feeding.
European Journal of Pharmacology 1990;186:61-70.
42 Smith GP.
Dopamine and food reward.
In: Morrison AM, Fluharty SJ, eds. Progress in psychobiology and physiological
psychology.Vol.15. New York: Academic Press 1995:83-144.
43 Stellar JR, Stellar E.
The Neurobiology of motivation and reward.
New York: Springer-Verlag 1985.
44 Xenakis S, Sclafani A.
The effects of pimozide on the consumption of a palatable saccharin-glucose
solution in the rat.
Pharmacology, Biochemistry and Behavior 1981;15:435-442.
45 Xenakis S, Sclafani A.
The dopaminergic mediation of a sweet "reward" in normal and
VMH hyperfagic rats.
Pharmacology, Biochemistry and Behavior 1982;16:293-302.
46 Berridge KC.
Substantia nigra 6OH-DA lesions mimic striatopallidal disruption of syntactic
grooming chains: a neural systems analysis of sequence control.
Psychobiology 1989;17:377-385.
47 Berridge KC, Venier IL, Robinson TE.
Taste reactivity analysis of 6-hidroxidopamine-induced aphagia: implications
for arousal and anhedonia hypotesis of dopamine function.
Behavioral Neuroscience 1989;103:36-45.
48 de Rick M, Teitelbaum P.
The posture of catecolamine-depletion catalepsy: their possible adaptative
value in termoregulation.
Psycology and Behavior 1978;21:817-820.
49 Marshall JF, Richardson JS, Teitelbaum P.
Nigrostriatal bundle damage and the lateral hypotalamic syndrome.
Journal of Comprehensive Physiology and Psychology 1974;87:808-830.
50 Price MT, Fibiger HC.
Discriminated escape learning and response to electric shock after 6-hydroxidopamine
lesions of the nigro-neostriatal dopaminergic projection.
Pharmacology, Biochemistry and Behavior 1975;3:285-290.
51 Qian M, Johnson AE, Sodersten P.
CCK-8 inhibits ingestive Behavior in rats with lateral hypotalamic 6OH-DA
lesions.
Neuroreport 1998;9:2763-2767.
52 Schallert T, Wischaw IQ, Ramirez VD, Teitelbaum P.
Neurotrasmitters and the regulation of food intake.
Progress in Brain Research 1975;42:235-249.
53 Schwartz M, Teitelbaum P.
Nigrostriatal bundle damage and lateral hypothalamic syndrome.
Journal of Comprehensive Physiology and Psychology 1974;87:808-830.
54 Stricker EM, Zigmond MJ.
Brain catecholamines and lateral hypotalamic syndrome.
In: Novin D, Wyrwicka W, Bray G, eds. Hunger: Basic Mechanisms and clinical
implications. New York: Raven Press 1976:19-32.
55 Teitelbaum P, Wolgin DL.
Abnormal gait sequence in locomotion after atropine treatment of catecholamine-deficient
akinetic rats.
Proceedings of the National Academy of Sciences of the United States of America
1987;84:8750-8753.
56 Ungerstedt U.
Adipsia and aphagia after 6-OHDA induced degeneration of the nigrostriatal
dopamine system.
Acta Physiologica Scandinavica 1971;367:95-122.
57 Zigmond MJ, Striker EM.
Deficits in feeding Behavior after intraventricular injection of 6-OHDA
in rats.
Science 1972;177:1211-1214.
58 Ettenberg A.
Dopamine, neuroleptics and reinforced Behavior.
Neuroscience and Biobehavioral Reviews 1989;13:105-111.
59 Blackburn JR, Pillips AG, Jakubovic A, Fibiger A.
Dopamine and preparatory Behavior: II. A neurochemical analysis.
Behavioral Neuroscience 1989;103:15-23.
60 Kiyatkin EA, Gratton A.
Electrochemical monitoring of extracellular dopamine of rats lever-pressing
for food.
Brain Research 1994;652:225-234.
61 Phillips AG, Pfaus JG, Blaha CD.
Dopamine and motivated Behavior: insights provided by in vivo analyses.
In: Willner P, Scheel-Kruger J, eds. The mesolimbic Dopamine system: From
motivation to action. Chichester: Wiley 1991:199-224.
62 Phillips AG, Blaha CD, Pfau JG, Blackburn JR.
Neurobiological correlates of positive emotional states: Dopamine, anticipation,
and reward.
In: Strongman KT, ed. International Review of Studies on Emotion. Vol.
2. New York: Wiley 1992:31-50.
63 Richardson NR, Gratton A.
Behavior-relevant changes in nucleus accumbens dopamine transmission elicited
by food reinforcement: an electrochemical study in rat.
Journal of Neuroscience 1996;16:8160-8169.
64 Simansky KJ, Bourbonais KA, Smith GP.
Food-related stimuli increase the ratio of 3,4-dhydroxyphenylacetic acid
to dopamine in the hypothalamus.
Pharmacology, Biochemistry and Behavior 1985;23:253-258.
65 Apicella P, Liungberg T, Scarnati E, Schultz W.
Responses to "reward" in monkey dorsal and ventral striatum.
Experimental Brain Research 1991;85:491-500.
66 Kosobud AE, Harris GC, Chapin JK.
Behavioral association of neuronal activity in the ventral tegmental area
of the rat.
Journal of Neuroscience 1994;14:7117-7129.
67 Schultz W.
Responses of midbrain dopamine neurons to Behavioral trigger stimuli in
the monkey.
Journal of Neurophysiology 1986;56:1439-1461.
68 Schultz W, Apicella P, Ljungberg T, Romo R, Scarnato E.
Reward-related activity in the monkey striatum and substantia nigra.
Progress in Brain Research 1993;99:227-235.
69 Strecker RE, Steinfels GF, Jacobs BL.
Dopaminergic unit activity in freely moving cats: lack of relationship to
feeding, satiety and glucose injection.
Brain Research 1983;260:317-321.
70 Di Ciano P, Blaha CD, Phillips AG.
Conditioned changes in dopamine oxidation currents in the nucleus accumbens
of rats by stimuli paired with self-administration or yoked-administration
of d-amphetamine.
European Journal of Neuroscience 1998;10:1121-1127.
71 Kiyatkin EA, Stein EA.
Conditioned changes in nucleus accumbens dopamine signal estabilished by
intravenous cocaine in rats.
Neuroscience Letters 1996;211:73-76.
72 Kiyatkin EA, Wise RA, Gratton A.
Drug and Behavior-associated changes in related electrochemicals during
intravenous heroin self-administration in rats.
Synapse 1993;14:60-72.
73 Clarke SN, Parker LA.
Morphine-induced modification of quinine palatability: effects of
multiple morphine-quinine trials.
Pharmacology, Biochemistry and Behavior 1995;51:505-508.
74 Cleary J, Weldon DT, Hare E, Billington C, Levine AS.
Naloxone effects on sucrose-motivated Behavior.
Psychopharmacology 1996;126:110-114.
75 Cooper SJ, Jackson A, Morgan R, Carter R.
Evidence for opiate receptor involvment in the consumption of a high palatability
diet in nondeprived rat.
Neuropeptides 1985;5:345-348.
76 Doyle TG, Gosnell BA.
Morphine enhances hedonic taste palatability in rats.
Pharmacology, Biochemistry and Behavior 1993;46:745-749.
77 Higgs S, Cooper SJ.
Midazolam-induced rapid changes in liking Behavior: evidence for involvment
of endogenous opioide peptides.
Psychopharmacology 1997;131:278-286.
78 Hill KG, Kiefer SW.
Naltrexone treatment increases the aversiveness of alcohol for outbred
rats.
Alcoholism, Clinical and Experimental Research 1997;21:637-641.
79 Levine AS, Weldon DT, Grace M, Cleary JP, Billington CJ.
Naloxone blocks the pat portion of feeding driven by sweet taste in food-restricted
rats.
American Journal of Physiology 1995;268:248-252.
80 Parker LA, Maier S, Rennie M, Crebolder J.
Morphine- and naltrexone-induced modification of palatability: analysis
by the taste reactivity test.
Behavioral Neuroscience 1992;106:999-1010.
81 Pecina S, Berridge KC.
Central enhancement of taste pleasure by intraventricular morphine.
Neurobiology 1995;3:269-280.
82 Pecina S, Berridge KC.
Morphine microinjections enhance feeding and palatability in the shell
but not core of nucleus accumbens.
Neuroscience Abstracts 1996;22:1408.
83 Welch CC, Kim EM, Grace MK, Billington CJ, Levin AS.
Palatability induced hyperphagia increase hypotalamic dynorphine
peptide and mRNA levels.
Brain Research 1996;721:126-131.
84 Berridge KC, Pecina S.
Benzodiazepines, appetite, and taste palatability.
Neuroscience and Biobehavioral Reviews 1995;19:121-131.
85 Cooper SJ.
Benzodiazepines as appetitive-enanching compounds.
Appetite 1980;1:17-19.
86 Cooper SJ, Estall LB.
Behavioral pharmacology of food, water and salt intake in relation to drug
actions at benzodiazepione receptors.
Neuroscience and Biobehavioral Reviews 1985;9:5-19.
87 Cooper SJ, Higgs S.
The benzodiazepine agonist midazolam microinjected into the rat parabrachial
nucleus produces hyperphagia.
Society for Neuroscience Abstract 1994;20:1285.
88 Parker LA.
Chlordiazepoxide enhances the of lithium-, amphetamine-, and saline-paired
saccharin solution.
Pharmacology, Biochemistry and Behavior 1995;50:345-349.
89 Pecina S, Berridge KC.
Brainstem mediates benzodiazepine enhancement of taste palatability: comparison
of diazepam microinjections into fourth versus lateral ventricles.
Brain Research 1996;727:22-30.
90 Soderpalm AHV, Hansen S.
Benzodiazepines enhance the consumption and palatability of alcohol in
the rat.
Psychopharmacology 1998;137:215-222.
91 Treit D, Berridge KC.
A comparison of benzodiazepine, serotonin, and dopamine agents in the taste-reactivity
paradigm.
Pharmacology, Biochemistry and Behavior 1990;37:451-456.
92 Berridge KC.
Food reward: brain substrates of wanting and liking.
Neuroscience and Biobehavioral Reviews 1996;20:1-25.
93 Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis
DJ, Mann JJ.
Autoradiographic demonstration of increased serotonin 5-HT2 and
beta-adrenergic receptor binding sites in the brain of suicide victims.
Archives of General Psychiatry 1990;47:1038-1047.
94 Mayberg HS, Robinson RG, Wong DF, Parikh R, Bolduc P, e Coll.
PET imaging of cortical S2 receptors after stroke: lateralized changes
and relationship to depression.
American Journal of Psychiatry 1988;145:937-943.
95 Mayberg HS, Parikh RM, Morris PLP, Robinson RG.
Spontaneous remission of post-stroke depression and temporal changes in
cortical S2-serotonin receptors.
Journal of Neuropsychiatry and Clinical Neuroscience 1991;3:80-83.
96 Mayberg HS, Ross CA, Dannals RF, e Coll.
Elevated mu opiate receptors measured by PET in patients with depression.
Journal of Cerebral Blood Flow and Metabolism 1991;11(suppl):821.
97 Simon H, LeMoal M, Calas A.
Efferents and afferents of the ventral-tegmental-A10 region studied after
local injection of 3H-leucine and horse radish peroxidase.
Brain Research 1979;178:17-40.
98 Di Chiara G.
The role of dopamine in drug abuse viewed from the prospective of its role
in motivation.
Drug and Alcohol Dependence 1995;38:95-137.
99 Di Chiara G.
A motivational learning hypotesis of the role of mesolimbic dopamine in
compulsive drug use.
Journal of Psychopharmacology 1998;12:54-67.
100 Schultz W, Dayan P, Montague PR.
A neural substrate of prediction and reward.
Science 1997;275:1593-1599.
101 Mayberg HS.
Limbic-Cortical Dysregulation: A Proposed Model of Depression.
Journal of Neuropsychiatry and Clinical Neuroscience 1997;9:471-481.
102 Baleydier C, Mauguiere F.
The duality of cingulate gyrus in the rhesus monkey: neuroanatomical study
and functional hypothesis.
Brain 1980;103:525-554.
103 Devinsky O, Morrel MJ, Vogt BA.
Contributions of anterior cingulate cortex to Behavior.
Brain 1995;118:279-306.
104 Dolan RJ, Bench Cj, Liddle PF, Friston KJ, Frith CD, Grasby PM, Frackowiak
RS.
Dorsolateral prefrontal cortex dysfunction in the major psychoses: symptom
or disease specificity?
Journal of Neurology, Neurosurgery and Psychiatry 1993;56:1290-1294.
105 Liotti M, Tucker DM.
Emotions in asymmetric corticolimbic networks.
In: Davidson RJ, Hugdahl K eds. Brain Asymmetry. Cambridge, MA:
MIT Press 1995:389-423.
106 Mayberg HS.
Clinical correlates of PET and SPECT defects in dementia.
Journal of Clinical Psychiatry 1994; 55:12-21.
107 Mesulam MM.
Patterns in Behavioral neuroanatomy: association areas, the limbic system,
and emispheric specialization.
In: Mesulam MM, ed. Principles of Behavioral Neurology. Philadelphia:
FA Davis 1985:1-70.
108 Morecraft RJ, Geula C, Mesulam MM.
Architecture of connectivity within a cingulo-corto-parietal neurocognitive
network for directed attention.
Archives of Neurology 1993;50:279-284.
109 Vogt BA, Pandya DN.
Cingulate cortex of the rhesus monkey: II. Cortical afferents.
Journal of Comprehensive Neurology 1987; 262:271-289.
110 Augustine JR.
The insular lobe in primates including humans.
Neurology Research 1985;7:2-10.
111 Cowan PJ.
Biological markers of depression.
Psychological Medicine 1991;21:831-836.
112 Damasio AR.
Descartes’ Error and future of human life.
Scientific American 1994;271:144.
113 Neafsey EJ.
Prefrontal cortical control of the autonomic nervous system: anatomical
and physiological observations.
Progress in Brain Research 1990;85:147-165; discussion 165-166.
114 Rolls ET.
Connections, functions and dysfunctions of limbic structures, the prefrontal
cortex and hypotalamus.
In: Swash M, Kennard C, eds. The Scientific Basis of Clinical Neurology.
London: Churchill Livingstone 1985:201-213.
115 Akiskal HS, McKinney WT Jr.
Overview of recent research in depression: integration of ten conceptual
models into a comprehensive clinical frame.
Archives of General Psychiatry 1975;32:285-305.
116 McKinney WT.
Animal models of depression: an overview.
Psychiatric Developments 1984;2:77-96.
117 McKinney WT.
Basis of development of animal models in psychiatry: an overview.
Basel: Birkhäuser Verlag 1989:3-17.
118 Papp M, Willner P, Muscat R.
An animal model of anhedonia: attenuation of sucrose consumption and place
preference conditioning unpredictable mild stress.
Psychopharmacology (Berlin) 1991;104:255-259.
119 Papp M, Muscat R, Willner P.
Subsensivity to rewarding and locomotor stimulant effects of a dopamine
agonist following chronic mild stress.
Psychopharmacology (Berlin) 1993;110:152-158.
120 Willner P, Muscat R, Papp M.
Chronic mild stress-induced anhedonia: A realistic animal model of depression.
Neuroscience and Biobehavioral Reviews 1992;16:525-534.
121 Willner P, Lappas S, Cheeta S, Muscat R.
Reversal of stress-induced anhedonia by dopamine receptor agonist, pramipexole.
Psychopharmacology (Berlin) 1994;115:454-462.
122 Moreau JL, Jenck F, Martin JR, Mortas P, Haefely WE.
Antidepressant treatment prevents chronic unpredictable mild stress-induced
anhedonia as assessed by ventral tegmental selfstimulation Behavior in rats.
European Neuropsychopharmacology 1992;2:43-49.
123 Muscat R, Papp M, Willner P.
Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine
and maprotiline.
Psychopharmacology 1992;109:433-438.
124 Sampson D, Muscat R, Willner P.
Reversal of antidepressant action by DA antagonists in animal model of
depression.
Psychopharmacology (Berlin) 1991;104:491-495.
125 Willner P, Towell A, Sampson D, Sophokleous S, Muscat R.
Reduction of sucrose preference by chronic mild stress and its restoration
by triciclic antidepressant.
Psychopharmacology (Berlin) 1987;93:358-364.
126 Sampson D, Muscat R, Willner P.
Reversal of antidepressant action by DA antagonists in animal model of
depression.
Psychopharmacology (Berlin) 1991;104:491-495.
127 Willner P, Towell A, Sampson D, Sophokleous S, Muscat R.
Reduction of sucrose preference by chronic mild stress and its restoration
by triciclic antidepressant.
Psychopharmacology (Berlin) 1987;93:358-364.
128 Moreau JL, Jenck F, Martin JR, Mortas P, Haefely WE.
Effects of moclobomide, a new generation reversible MAO-A inhibitor in
a novel animal model of depression.
Pharmacopsychiatry 1993;26:30-33.
129 Cheeta S, Broekkamp CLE, Willner P.
Stereospecific reversal of stress-induced anhedonia by mianserin and its
(+) enantiomer.
Psychopharmacology (Berlin) 1994;116:523-528.
130 Stamford JA, Muscat R, O’Connor JJ, Patel JJ, Wieczorek WJ, Kruk
ZL, Willner P.
Voltammetric evidence that subsensitivity to "reward" following
chronic mild stress is associated with increase release of mesolimbic dopamine.
Psychopharmacology (Berlin) 1991;105:275-282.
131 Willner P, Klimek V, Golembiowska K, Muscat R.
Changes in mesolimbic dopamine may explain stress-induced anhedonia.
Psychobiology 1991;19:79-84.
132 Muscat R, Sampson D, Willner P.
Dopaminergic mechanism of imipramine action in an animal model of
depression.
Biological Psychiatry 1990;28:223-230.
133 Muscat R, Papp M, Willner P.
Antidepressant-like actions of DA agonists in animal model of depression.
Biological Psychiatry 1992;31:937-946.
134 Papp M, Muscat R, Willner P.
Behavioral sensitivization to a dopamine agonist is associated with recovery
from stress-induced anhedonia.
Psychopharmacology (Berlin) 1993;manca volume e pagina.
135 Auriacombe M, Reneric JP, Le Moal M.
Animal models of anhedonia.
Psychopharmacology (Berlin) 1997;143:337-338.
136 Forbes NF, Stewart CA, Matthews K, Reid IC.
Chronic mild stress and sucrose consumption: Validity as model of depression.
Physiology and Behavior 1996;60:1481-1484.
137 Di Chiara G, Tanda G.
Blunting of reactivity of dopamine transmission to palatable food: a biochemical
marker of anhedonia in the CMS model?
Psychopharmacology (Berlin) 1997;134:351-353.
138 Willner P.
Validity, reliability and utility of the chronic mild stress model of depression:
a 10-year review and avaluation.
Psychopharmacology (Berlin) 1997;134:319-329.
139 Hatcher JP, Bell DJ, Hagan JJ.
CMS induced reductions in saccharin intake depend upon nutritive state.
Journal of Psychopharmacology 1996;10:27.
140 Forbes NF, Stewart CA, Matthews K, Reid IC.
Chronic mild stress and sucrose consumption: Validity as model of depression.
Physiology and Behavior 1996;60:1481-1484.
141 Reid I, Forbes N, Stewart C, Matthews K.
Chronic mild stress and depressive disorder: a useful new model?
Psychopharmacology (Berlin) 1997;134:365-367.
142 D’Aquila P, Newton J, Willner P.
Diurnal variation in the effect of chronic mild stress on sucrose
intake and preference.
Physiology and Behavior 1997;62:421-426.
143 Charkrabarti A, Rossby SP, Manier DH, Perrin C, Onaivi ES, Sulser F.
Molecular correlates of a chronic mild stress model of depression.
Society for Neuroscience Abstracts 1996;22:2060.
144 Graibyel AM.
Neurotrasmitters and neuromodulators in the basal ganglia.
Trends in Neurosciences 1990;13:244-254.
145 Valverde O, e Coll.
The attenuation of morphine-conditioned place preference following chronic
mild stress is reversed by a CCKB receptor antagonist.
Psychopharmacology (Berlin) 1997;131:79-85.
146 Berger SP, Hall S, Mickalian JD, Reid MS,Crawford CA, Delucchi K, Carr
H, Hall S.
Haloperidol antagonism of cue-elicited cocaine craving.
Lancet 1996;347:504-508.
147 Brauer LH, Goudie AJ, de Wit H.
Dopamine ligands and the stimulus effects of amphetamine: animal models
versus human laboratory data.
Psychopharmacology (Berlin) 1997;130:2-13.
148 Modell JG, Mountz JM, Glaser FB, Lee JY.
Effect of haloperidol on measures of craving and impaired control in alcholic
subjects.
Alcoholism, Clinical and Experimental Research 1993;17:234-240.